ReviewNanoscale advances2026
Antimicrobial nanomaterials at the nanoscale: design principles, mechanisms, and global challenges.
Review in Nanoscale advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Evaluation of the synergistic and antagonistic antibacterial effects of pulsed electromagnetic fields combined with ciprofloxacin and nanochitosan.Scientific reports · 2026Article
- Silver-based N-heterocyclic carbene (NHC) complexes as emerging strategies against antimicrobial resistance.Archives of microbiology · 2026Review
- Data-Driven Engineering of Antimicrobial Nanomaterials for Food Safety and Biomedical Systems.Nanomaterials (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rapid escalation of antimicrobial resistance (AMR) represents a major global health challenge, undermining the clinical efficacy of conventional antibiotics and driving the demand for alternative therapeutic strategies. Advances in nanoscience have positioned nanoscale materials as a powerful platform for the development of next generation antimicrobial systems, owing to their precisely tunable physicochemical features and ability to operate through multiple resistance evasive modes of action. This review provides a comprehensive overview of recent progress in antimicrobial nanomaterials, encompassing metallic and metal oxide nanoparticles, polymeric and carbon based nanostructures, as well as multifunctional hybrid architectures. Key antimicrobial mechanisms, including controlled ion release, reactive oxygen species generation, membrane perturbation, and synergistic chemical and physical interactions at the nano bio interface, are critically discussed. Particular attention is given to the growing class of stimuli responsive and smart nanomaterials that enable spatiotemporal activation, enhanced targeting, and improved therapeutic precision. The integration of antimicrobial functionality with anti-inflammatory, regenerative, and diagnostic capabilities highlights the versatility of nanoscale systems for biomedical applications such as wound management, implant surface engineering, biofilm mitigation, and targeted drug delivery. Despite significant advances, challenges related to cytocompatibility, biodegradability, scalable manufacturing, and regulatory harmonization remain. Finally, emerging directions including nanozymes, metal organic frameworks, artificial intelligence assisted material design, and antimicrobial 3D printed nanocomposites are discussed, underscoring the pivotal role of nanoscale innovation in addressing AMR and advancing future antimicrobial technologies.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.